Atara Biotherapeutics Inc., a company in which Mexican billionaire Carlos Slim owns shares, filed for an initial public offering to expand kidney disease research – an illness that runs in the Slim family.
Source: Technology
Author
Harry Joiner
“… a dominant recruiter in the client-side multichannel ecommerce space …” — SearchEngineWatch.com